ALEXANDRIA, Va., March 24 -- United States Patent no. 12,584,143, issued on March 24, was assigned to XBRANE BIOPHARMA AB (Solna, Sweden).

"Combination of TIS sequence and signal peptide sequence for expressing a recombinant protein" was invented by Kiavash Mirzadeh (Solna, Sweden), Veronica Ramberg (Ekero, Sweden), Nathalie Chatzissavidou (Sodertalje, Sweden), Patrik Samuelson (Saltsjobaden, Sweden), Siavash Bashiri (Stockholm), Per Edebrink (Stockholm), Joanne Stevenson (Sodertalje, Sweden) and David Vikstrom (Upplands Vasby, Sweden).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to DNA constructs comprising a novel TIS sequence. The TIS sequence transcribes into an RNA motif t...